By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Haleon plc

Haleon plc (HLN.L)

LSE Currency in GBP
£360.00
-£2.30
-0.63%
Last Update: 28 Aug 2025, 15:49
£32.28B
Market Cap
2.29K
P/E Ratio (TTM)
2.44%
Forward Dividend Yield
£346.10 - £419.50
52 Week Range

HLN.L Stock Price Chart

Explore Haleon plc interactive price chart. Choose custom timeframes to analyze HLN.L price movements and trends.

HLN.L Company Profile

Discover essential business fundamentals and corporate details for Haleon plc (HLN.L) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

18 Jul 2022

Employees

24.56K

CEO

Brian James McNamara

Description

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

HLN.L Financial Timeline

Browse a chronological timeline of Haleon plc corporate events including earnings releases, dividend announcements, and stock splits.

Dividend declared on 14 Aug 2025

A dividend of £2.20 per share was announced, adjusted to £2.20. The dividend will be paid on 18 Sept 2025.

Earnings released on 31 Jul 2025

EPS came in at £0.10 surpassing the estimated £0.09 by +2.11%, while revenue for the quarter reached £5.66B , missing expectations by -0.81%.

Earnings released on 8 May 2025

Dividend declared on 24 Apr 2025

A dividend of £3.41 per share was announced, adjusted to £3.41. The dividend was paid on 5 Jun 2025.

Earnings released on 27 Feb 2025

EPS came in at £0.09 surpassing the estimated £0.09 by +2.24%, while revenue for the quarter reached £2.76B , missing expectations by -49.49%.

Earnings released on 31 Oct 2024

EPS came in at £4.58 surpassing the estimated £4.53 by +1.10%, while revenue for the quarter reached £2.78B , beating expectations by +1.88%.

Dividend declared on 15 Aug 2024

A dividend of £2.00 per share was announced, adjusted to £2.00. The dividend was paid on 19 Sept 2024.

Earnings released on 1 Aug 2024

EPS came in at £3.84 surpassing the estimated £3.64 by +5.49%, while revenue for the quarter reached £2.78B , missing expectations by -50.74%.

Earnings released on 1 May 2024

EPS came in at £5.17 surpassing the estimated £4.66 by +10.94%, while revenue for the quarter reached £2.92B , missing expectations by -0.48%.

Dividend declared on 14 Mar 2024

A dividend of £4.20 per share was announced, adjusted to £4.20. The dividend was paid on 16 May 2024.

Earnings released on 29 Feb 2024

EPS came in at £3.27 falling short of the estimated £4.66 by -29.83%, while revenue for the quarter reached £2.77B , missing expectations by -50.13%.

Earnings released on 2 Nov 2023

EPS came in at £5.02 surpassing the estimated £4.60 by +9.13%, while revenue for the quarter reached £2.80B , beating expectations by +0.88%.

Dividend declared on 24 Aug 2023

A dividend of £1.80 per share was announced, adjusted to £1.80. The dividend was paid on 5 Oct 2023.

Earnings released on 2 Aug 2023

EPS came in at £3.61 falling short of the estimated £9.41 by -61.64%, while revenue for the quarter reached £2.75B , missing expectations by -3.39%.

Earnings released on 3 May 2023

EPS came in at £4.89 falling short of the estimated £5.24 by -6.68%, while revenue for the quarter reached £2.99B .

Dividend declared on 16 Mar 2023

A dividend of £2.40 per share was announced, adjusted to £2.40. The dividend was paid on 27 Apr 2023.

Earnings released on 2 Mar 2023

EPS came in at £3.37 falling short of the estimated £5.00 by -32.60%, while revenue for the quarter reached £3.79B , beating expectations by +30.90%.

Earnings released on 10 Nov 2022

EPS came in at £5.43 surpassing the estimated £0.04 by +12.29K%, while revenue for the quarter reached £2.89B , beating expectations by +3.18%.

Earnings released on 11 Jul 2022

EPS came in at £0.02 falling short of the estimated £0.09 by -76.31%, while revenue for the quarter reached £2.56B , missing expectations by -51.75%.

Earnings released on 31 Mar 2022

EPS came in at £0.04 , while revenue for the quarter reached £2.63B .

Earnings released on 31 Dec 2021

EPS came in at £0.06 , while revenue for the quarter reached £1.47B .

Earnings released on 30 Sept 2021

EPS came in at £0.04 , while revenue for the quarter reached £2.49B .

Earnings released on 30 Jun 2021

EPS came in at £0.03 , while revenue for the quarter reached £2.27B .

Earnings released on 31 Mar 2021

EPS came in at £0.03 , while revenue for the quarter reached £2.31B .

HLN.L Stock Performance

Access detailed HLN.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run